Literature DB >> 30528239

Claudin-7 downregulation induces metastasis and invasion in colorectal cancer via the promotion of epithelial-mesenchymal transition.

Kun Wang1, Tengyan Li2, Chang Xu1, Yuhan Ding1, Wenjing Li3, Lei Ding4.   

Abstract

The dysregulation of the tight junctions (TJs) protein claudin-7 is closely related to the development and metastasis of colorectal cancer (CRC). The aim of this study was to investigate the expression of claudin-7 and characterize the relationship between claudin-7 expression and epithelial-mesenchymal transition (EMT) in CRC. In this study, the expression of claudin-7, E-cadherin, vimentin and snail-1 was detected by immunohistochemistry (IHC) in a set of 80 CRC specimens comprising 20 specimens each of well-differentiated, moderately differentiated, poorly differentiated and liver metastases tissues. The correlation between claudin-7 and EMT-related proteins in the stably transfected claudin-7 knockdown HCT116 cell line was analyzed by IHC, immunofluorescence (IF), Western blotting (WB) and nude mouse xenograft models. The results revealed that the expression of claudin-7 was downregulated as CRC tissue differentiation grade decreased, and that low claudin-7 expression corresponded to the downregulation of E-cadherin (r = 0.725, p < 0.001) and upregulation of vimentin (r = -0.376, p = 0.001) and snail-1 (r = -0.599, p < 0.001). Additionally, in the claudin-7 knockdown HCT116 cell line, the staining intensity and expression of E-cadherin was decreased, while the immunoreactivity and expression of vimentin and snail-1 was increased. Futhermore, the result of tumor formation experiment was consistent with CRC tissues. In conclusion, the expression of claudin-7 in CRC is downregulated as differentiation grade decreases. Claudin-7 downregulation may promote the invasion and metastasis of CRC by regulating EMT. Our results provide new perspectives for a potential therapeutic target for CRC.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Claudin-7; Colorectal cancer; Epithelial-mesenchymal transition; Metastasis

Mesh:

Substances:

Year:  2018        PMID: 30528239     DOI: 10.1016/j.bbrc.2018.10.049

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Is High Expression of Claudin-7 in Advanced Colorectal Carcinoma Associated with a Poor Survival Rate? A Comparative Statistical and Artificial Intelligence Study.

Authors:  Victor Ianole; Mihai Danciu; Constantin Volovat; Cipriana Stefanescu; Paul-Corneliu Herghelegiu; Florin Leon; Adrian Iftene; Ciprian-Gabriel Cusmuliuc; Bogdan Toma; Vasile Drug; Delia Gabriela Ciobanu Apostol
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

2.  Evaluation of clinical significance of claudin 7 and construction of prognostic grading system for stage II colorectal cancer.

Authors:  Ji-Chuan Quan; Jian Peng; Xu Guan; Zheng Liu; Zheng Jiang; Hai-Peng Chen; Meng Zhuang; Song Wang; Peng Sun; Hong-Ying Wang; Shuang-Mei Zou; Xi-Shan Wang
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

3.  CDX2 expression and perioperative patient serum affects the adhesion properties of cultured colon cancer cells.

Authors:  Johanne Davidsen; Stine Bull Jessen; Sara Kehlet Watt; Sylvester Larsen; Katja Dahlgaard; Tove Kirkegaard; Ismail Gögenur; Jesper T Troelsen
Journal:  BMC Cancer       Date:  2020-05-14       Impact factor: 4.430

4.  Sulforaphane metabolites inhibit migration and invasion via microtubule-mediated Claudins dysfunction or inhibition of autolysosome formation in human non-small cell lung cancer cells.

Authors:  Zhongnan Zheng; Kai Lin; Yabin Hu; Yan Zhou; Xiaoyan Ding; Yalin Wang; Wei Wu
Journal:  Cell Death Dis       Date:  2019-03-15       Impact factor: 8.469

Review 5.  Claudin Family Participates in the Pathogenesis of Inflammatory Bowel Diseases and Colitis-Associated Colorectal Cancer.

Authors:  Liguo Zhu; Jing Han; Li Li; Ying Wang; Ying Li; Shenghong Zhang
Journal:  Front Immunol       Date:  2019-06-27       Impact factor: 7.561

6.  Catechin and Procyanidin B2 Modulate the Expression of Tight Junction Proteins but Do Not Protect from Inflammation-Induced Changes in Permeability in Human Intestinal Cell Monolayers.

Authors:  Massimiliano G Bianchi; Martina Chiu; Giuseppe Taurino; Furio Brighenti; Daniele Del Rio; Pedro Mena; Ovidio Bussolati
Journal:  Nutrients       Date:  2019-09-21       Impact factor: 5.717

Review 7.  Role of Claudin Proteins in Regulating Cancer Stem Cells and Chemoresistance-Potential Implication in Disease Prognosis and Therapy.

Authors:  Saiprasad Gowrikumar; Amar B Singh; Punita Dhawan
Journal:  Int J Mol Sci       Date:  2019-12-20       Impact factor: 5.923

8.  Claudin-7 Inhibits Proliferation and Metastasis in Salivary Adenoid Cystic Carcinoma Through Wnt/β-Catenin Signaling.

Authors:  Huan Ji; Xu Ding; Wei Zhang; Yang Zheng; Hongming Du; Yangyu Zheng; Haiyang Song; Meng Li; Yue Jiang; Jiaxiang Xie; Ming Wu; Pengfei Jiao; Zeyu Wang; Heming Wu; Yi Zhong
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

9.  The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance.

Authors:  Yichao Hou; Lidan Hou; Yu Liang; Qingwei Zhang; Xialu Hong; Yu Wang; Xin Huang; Ting Zhong; Wenjing Pang; Ci Xu; Liming Zhu; Lei Li; Jingyuan Fang; Xiangjun Meng
Journal:  Neoplasia       Date:  2020-09-28       Impact factor: 5.715

10.  Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling.

Authors:  Chang Xu; Yu-Han Ding; Kun Wang; Mengdi Hao; Huimin Li; Lei Ding
Journal:  J Transl Med       Date:  2021-07-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.